Albumin Thiol Oxidation and Serum Protein Carbonyl Formation Are Progressively Enhanced with Advancing Stages of Chronic Kidney Disease

Overview

Journal Clin Exp Nephrol

Publisher Springer

Specialty Nephrology

Date 2009 Apr 14

PMID 19363646

Citations 28

Authors

Yukie Matsuyama

Hiroyuki Terawaki

Tomoyoshi Terada

Seiichi Era

Affiliations

Soon will be listed here.

Abstract

Background: Oxidative stress is enhanced in advanced chronic kidney disease (CKD) patients and recognized as a main contributor to cardiovascular disease. Carbonyl stress is also known to be enhanced in advanced CKD; however the precise relationship between oxidative stress and carbonyl stress is not clear. The aim of this study was to investigate potential relationships between oxidative stress, carbonyl stress, and renal function among predialysis patients with CKD.

Methods: A total of 32 predialysis CKD patients (22 male, 10 female) were divided into four groups according to their values for creatinine clearance (Ccr) (group A, > or =60 ml/min; group B, 45-59 ml/min; group C, 30-44 ml/min; group D, < or =29 ml/min). As main markers of oxidative and carbonyl stresses, the redox state of Cys-34 (free thiol group) of human serum albumin [HSA(Cys-34)-redox] and the carbonyl content of serum proteins were employed, respectively.

Results: The values for the fraction of both reversibly oxidized HSA [f(HNA-1)] and irreversibly oxidized HSA [f(HNA-2)] significantly increased with a decrease in renal function (group A, 21.0 +/- 3.4 and 1.8 +/- 0.3%; group D, 31.1 +/- 4.1 and 2.7 +/- 0.9%, respectively). The value for carbonyl content also significantly increased with a decrease in renal function (group A, 0.7 +/- 0.1 nmol/mg protein; group D, 1.1 +/- 0.2 nmol/mg protein). There was a significant positive correlation between carbonyl content and the f(HNA-2) value, while such a correlation was not observed between carbonyl content and the f(HNA-1) value, suggesting that there is a close relationship between serum protein carbonylation and irreversible albumin thiol oxidation.

Conclusions: There is a close relationship between oxidative stress and carbonyl stress and these are enhanced in correlation with the level of renal dysfunction among predialysis CKD patients.

Citing Articles

Oxidative damage in the gastrocnemius predicts long-term survival in patients with peripheral artery disease.

Koutakis P, Hernandez H, Miserlis D, Thompson J, Papoutsi E, Mietus C NPJ Aging. 2024; 10(1):21.

PMID: 38580664 PMC: 10997596. DOI: 10.1038/s41514-024-00147-3.

Assessing the effects of tempol on renal fibrosis, inflammation, and oxidative stress in a high-salt diet combined with 5/6 nephrectomy rat model: utilizing oxidized albumin as a biomarker.

Liu B, Hu Y, Tian D, Dong J, Li B BMC Nephrol. 2024; 25(1):64.

PMID: 38395806 PMC: 10893674. DOI: 10.1186/s12882-024-03495-0.

Oxidative stress is associated with markers of renal dysfunction in children aged 6-9 years old in a South African population.

Matjuda E, Engwa G, Mungamba M, Sewani-Rusike C, Nkeh-Chungag B Pan Afr Med J. 2022; 42:35.

PMID: 35910048 PMC: 9288113. DOI: 10.11604/pamj.2022.42.35.26443.

The Interplay between Uremic Toxins and Albumin, Membrane Transporters and Drug Interaction.

da Cunha R, Azevedo C, Falconi C, Ruiz F, Liabeuf S, Carneiro-Ramos M Toxins (Basel). 2022; 14(3).

PMID: 35324674 PMC: 8949274. DOI: 10.3390/toxins14030177.

Blood Thiol Redox State in Chronic Kidney Disease.

Garavaglia M, Giustarini D, Colombo G, Reggiani F, Finazzi S, Calatroni M Int J Mol Sci. 2022; 23(5).

PMID: 35269995 PMC: 8911004. DOI: 10.3390/ijms23052853.

References

Terawaki H, Yoshimura K, Hasegawa T, Matsuyama Y, Negawa T, Yamada K . Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney Int. 2004; 66(5):1988-93. DOI: 10.1111/j.1523-1755.2004.00969.x. View

Lonn E, Yusuf S, Dzavik V, Doris C, Yi Q, Smith S . Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation. 2001; 103(7):919-25. DOI: 10.1161/01.cir.103.7.919. View

Go A, Chertow G, Fan D, McCulloch C, Hsu C . Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351(13):1296-305. DOI: 10.1056/NEJMoa041031. View

Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Nguyen A, Canteloup S, Dayer J . Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol. 1998; 161(5):2524-32. View

Tepel M, van der Giet M, Statz M, Jankowski J, Zidek W . The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial. Circulation. 2003; 107(7):992-5. DOI: 10.1161/01.cir.0000050628.11305.30. View

Miyata T, Van Ypersele De Strihou C, Kurokawa K, Baynes J . Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int. 1999; 55(2):389-99. DOI: 10.1046/j.1523-1755.1999.00302.x. View

Terawaki H, Matsuyama Y, Era S, Matsuo N, Ikeda M, Ogura M . Elevated oxidative stress measured as albumin redox state in continuous ambulatory peritoneal dialysis patients correlates with small uraemic solutes. Nephrol Dial Transplant. 2006; 22(3):968. DOI: 10.1093/ndt/gfl635. View

Levey A, Coresh J, Greene T, Stevens L, Zhang Y, Hendriksen S . Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006; 145(4):247-54. DOI: 10.7326/0003-4819-145-4-200608150-00004. View

Imai H, Hayashi T, Negawa T, Nakamura K, Tomida M, Koda K . Strenuous exercise-induced change in redox state of human serum albumin during intensive kendo training. Jpn J Physiol. 2002; 52(2):135-40. DOI: 10.2170/jjphysiol.52.135. View

10.

Sogami M, Nagoka S, Era S, Honda M, Noguchi K . Resolution of human mercapt- and nonmercaptalbumin by high-performance liquid chromatography. Int J Pept Protein Res. 1984; 24(2):96-103. DOI: 10.1111/j.1399-3011.1984.tb00933.x. View

11.

Cockcroft D, GAULT M . Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16(1):31-41. DOI: 10.1159/000180580. View

12.

Fukushima H, Miwa Y, Shiraki M, Gomi I, Toda K, Kuriyama S . Oral branched-chain amino acid supplementation improves the oxidized/reduced albumin ratio in patients with liver cirrhosis. Hepatol Res. 2007; 37(9):765-70. DOI: 10.1111/j.1872-034X.2007.00123.x. View

13.

Era S, Hamaguchi T, Sogami M, Kuwata K, Suzuki E, Miura K . Further studies on the resolution of human mercapt- and nonmercaptalbumin and on human serum albumin in the elderly by high-performance liquid chromatography. Int J Pept Protein Res. 1988; 31(5):435-42. DOI: 10.1111/j.1399-3011.1988.tb00900.x. View

14.

Agarwal R . Chronic kidney disease is associated with oxidative stress independent of hypertension. Clin Nephrol. 2004; 61(6):377-83. DOI: 10.5414/cnp61377. View

15.

Rule A, Jacobsen S, Schwartz G, Mosley T, Scott C, Kardia S . A comparison of serum creatinine-based methods for identifying chronic kidney disease in hypertensive individuals and their siblings. Am J Hypertens. 2006; 19(6):608-14. DOI: 10.1016/j.amjhyper.2005.10.025. View

16.

Soejima A, Matsuzawa N, Hayashi T, Kimura R, Ootsuka T, Fukuoka K . Alteration of redox state of human serum albumin before and after hemodialysis. Blood Purif. 2004; 22(6):525-9. DOI: 10.1159/000082524. View

17.

Suzuki E, Yasuda K, Takeda N, Sakata S, Era S, Kuwata K . Increased oxidized form of human serum albumin in patients with diabetes mellitus. Diabetes Res Clin Pract. 1992; 18(3):153-8. DOI: 10.1016/0168-8227(92)90140-m. View

18.

Nanayakkara P, van Guldener C, Ter Wee P, Scheffer P, van Ittersum F, Twisk J . Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the.... Arch Intern Med. 2007; 167(12):1262-70. DOI: 10.1001/archinte.167.12.1262. View

19.

Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A . Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet. 2000; 356(9237):1213-8. DOI: 10.1016/s0140-6736(00)02783-5. View

20.

Shurtz-Swirski R, Mashiach E, Kristal B, Shkolnik T, Shasha S . Antioxidant enzymes activity in polymorphonuclear leukocytes in chronic renal failure. Nephron. 1995; 71(2):176-9. DOI: 10.1159/000188708. View